Pooled analysis of this study RE-COVER II and the RE-COVER trial gave hazard ratios for recurrent VTE of 1.09 ( 95 % CI , 0.76-1 .57 ) , for major bleeding of 0.73 ( 95 % CI , 0.48-1 .11 ) , and for any bleeding of 0.70 ( 95 % CI , 0.61-0 .79 ) .